Novavax Inc NVAX

Healthcare Biotechnology

Novavax, Inc. is a biotechnology company, which discovers, develops and commercializes vaccines to prevent serious infectious diseases. The Company offers a differentiated vaccine platform that combines a recombinant protein approach, advanced nanoparticle technology and its patented Matrix-M adjuvant to enhance the immune response. It has one commercial program, for vaccines to prevent COVID-19, which includes Nuvaxovid prototype COVID-19 vaccine (NVX-CoV2373 or prototype vaccine) and Nuvaxovid updated COVID-19 vaccine (NVX-CoV2601 or updated vaccine) (collectively, COVID-19 Vaccine). The Company is advancing the development of other vaccine candidates, including its COVID19-Influenza Combination (CIC) vaccine candidate and additional vaccine candidates. Its COVID-19 Vaccine and its other vaccine candidates incorporate the Company’s proprietary Matrix-M adjuvant to enhance the immune response and stimulate higher levels of functional antibodies and induce a cellular immune response.

NDAQ:NVAX - Post by User

Novavax Inc

Bullboard Posts

Post by corOWNaviruson Mar 11, 2020 4:26pm

277 Views

Post# 30795388

CORONAVIRUS STOCKS ONLY PLAY IN TOWN

Simply put this is the greatest event since World War II All Coronavirus related stocks even the penny stocks remotely related to anything CORONAVIRUS WILL EXPLODE TO THE UPSIDE Greatest opportunity in a lifetime, unfortunately it is a virus that will kill many millions! This will not go away it will get enormous the cheapest stocks will give the biggest profits Good Luck to all

Bullboard Posts

@ the Bell: TSX advances to start off Christmas trading week